Oncolytics Biotech
ONCY
$1.18
Share price
-0.43%
Change (1 day)
-31.29%
Change (1 year)
Categories
Oncolytics Biotech (ONCY) - Cash on Hand
Cash on Hand as of December 2023 : $26.37 M
According to Oncolytics Biotech
's latest financial reports the company has $26.37 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Oncolytics Biotech - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $26.37 M | 11% |
| 2022-12-31 | $23.75 M | -26.62% |
| 2021-12-31 | $32.37 M | 32.23% |
| 2020-12-31 | $24.48 M | 126.03% |
| 2019-12-31 | $10.83 M | 7.71% |
| 2018-12-31 | $10.05 M | 6.9% |
| 2017-12-31 | $9.4 M | -10.51% |
| 2016-12-31 | $10.51 M | -44.08% |
| 2015-12-31 | $18.79 M | 34.79% |
| 2014-12-31 | $13.94 M | -45.46% |
| 2013-12-31 | $25.57 M | 19.43% |
| 2012-12-31 | $21.41 M | -37.28% |
| 2011-12-31 | $34.14 M | -20.46% |
| 2010-12-31 | $42.92 M | 32.33% |
| 2009-12-31 | $32.43 M | 197.06% |
| 2008-12-31 | $10.91 M | -56.8% |
| 2007-12-31 | $25.27 M | 6.57% |
| 2006-12-31 | $23.71 M | -31.62% |
| 2005-12-31 | $34.68 M | 22.82% |
| 2004-12-31 | $28.24 M | 76.52% |
| 2003-12-31 | $15.99 M | 163.18% |
| 2002-12-31 | $6.07 M | -44.43% |
| 2001-12-31 | $10.93 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $2.58 B | 9,707.66% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 36,570.18% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | $0.97 B | 3,602.79% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $34.01 M | 28.99% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 12,133.51% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | $77.39 M | 193.51% | 🇺🇸 USA |